AAM
XLRN

Alpine Associates Management’s Acceleron Pharma Inc. XLRN Stock Holding History

Alpine Associates Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-354,300
Closed -$61M – 63
2021
Q3 		$61M Buy
+354,300
New +$61M 1.98% 17